Table 1

Test for gender differences
Line Trait Male Female
No. Mean* SE No. Mean* SE p-value
BALB/cJ CBV 5 6.56 0.60 5 5.98 0.21 0.39
RBV 4 4.37 0.28 5 4.68 0.33 0.54
LBV 2.19 0.66 1.30 0.39
C57BL/6J CBV 5 5.50 0.82 4 3.75 0.22 0.11
RBV 3 5.10 0.50 4 4.60 0.44 0.49
LBV 0.40 0.96 −0.85 0.49
A/J CBV 5 7.32 0.49 5 6.96 0.61 0.66
RBV 5 7.20 0.42 5 7.68 0.43 0.45
LBV 0.12 0.65 0.72 0.75
DBA/2J CBV 4 6.52 0.25 3 7.53 0.88 0.26
RBV 5 6.64 0.25 4 6.95 0.43 0.52
LBV −0.12 0.35 0.58 0.98
CC034/TAU CBV 8 3.35 0.45 2 3.85 0.75 0.62
RBV 5 3.62 0.39 2 5.05 0.95 0.14
LBV −0.27 0.60 −0.12 1.21
CC188/TAU CBV 2 6.35 0.15 3 4.83 0.44 0.08
RBV 2 5.15 0.05 3 5.80 0.71 0.53
LBV 1.20 0.16 −0.97 0.84
CC711/TAU CBV 6 6.52 0.62 7 6.10 0.64 0.65
RBV 4 4.93 0.69 6 4.72 0.85 0.87
LBV 1.59 0.93 1.38 1.06

Comparison of control bone volume before infection (CBV), and residual bone volume (RBV) and loss of bone volume (LBV) following infection in males and females. Results are shown for four standard laboratory pure lines, and for three randomly chosen TAU CC lines.

CBV Control Bone Volume.

RBV Residual Bone Volume.

No. number of mice.

SE standard error.

* = × 10-3mm3.

Shusterman et al.

Shusterman et al. BMC Genetics 2013 14:68   doi:10.1186/1471-2156-14-68

Open Data